Lansoprazole Capsule, Delayed Release
Product Images NDC 68788-8621

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 68788-8621). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole Delayed-release Cap Usp 30mg (Bottle Label 30mg)

Lansoprazole Delayed-release Cap Usp 30mg (Bottle Label 30mg)
Label for Lansoprazole Delayed-Release Capsules USP 30 mg by Preferred Pharmaceuticals Inc. The label includes dosage information, storage instructions, and manufacturing details by Xiromed, LLC. The capsule is described as white and blue, imprinted with 30mg A263. The label also contains instructions in English and Spanish and cautions about the transfer of the drug.*
FDA Label Image

Figure-1.jpg (Figure 1)

Figure-1.jpg (Figure 1)
A line graph depicting the mean severity of day heartburn by study day for evaluable patients, comparing placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily. The graph plots mean heartburn severity scores over days from the start of treatment, showing a decrease in severity with Lansoprazole compared to placebo.*
FDA Label Image

Figure-2.jpg (Figure 2)

Figure-2.jpg (Figure 2)
A line graph showing the mean severity of night heartburn over days from the start of treatment. The y-axis represents severity from 0 (none) to 3 (severe), and the x-axis represents days from -5 to 60. Three lines indicate results for placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD, illustrating decreasing severity over time with treatment.*
FDA Label Image

Formula-structure.jpg (Image 01)

Formula-structure.jpg (Image 01)
Chemical structure diagram of lansoprazole displaying its molecular components and bonds, consistent with the active ingredient in Lansoprazole capsules 30 mg by Preferred Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.